查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016741

吸入麻醉市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034年

Inhalation Anesthesia Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球吸入麻醉市場規模達17.3億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到22.2億美元，2026年至2034年的複合年成長率（CAGR）為2.69%。目前，北美市場佔據主導地位，預計2025年將佔52.8%的市場。慢性病患者數量的增加，以及製藥公司、醫療設備製造商和醫療機構之間的合作，正在推動市場成長。此外，政府和私人醫療機構對先進設備的投入增加，也促進了吸入麻醉市場佔有率的擴大。

政府加強對醫療設施的投資，並提高了患者獲得外科手術治療和最新麻醉技術的途徑。新建醫院和手術中心增加了先進吸入麻醉系統的普及率。開發中國家麻醉醫師訓練計畫的進行，促進了安全有效麻醉劑的應用。印度和泰國等國醫療旅遊的興起，增加了吸入麻醉服務的需求。新興市場先進外科手術的普及，提高了SEVOFLURANE和DESFLURANE等現代麻醉劑的使用率。醫療保險覆蓋範圍的擴大，提高了需要吸入麻醉的外科手術治療的成本效益和可近性。官民合作關係（PPP）模式在醫療計畫中，促進了先進麻醉技術在醫療資源匱乏地區的應用。

創新麻醉機能夠實現手術期間吸入麻醉的精準監測和可控給藥。SEVOFLURANE等藥物藥物動力學的改進，使得麻醉誘導更快，術後恢復時間更短。麻醉機整合的軟體系統提高了工作流程效率，並降低了人為錯誤的風險。非侵入性監測技術確保了病人生命徵象的即時回饋，從而最佳化了麻醉管理，保障了病人安全。攜帶式和小型麻醉設備在門診和門診手術中心的應用日益廣泛。環保麻醉劑的研發降低了傳統吸入麻醉對環境的影響。兒童和老年人麻醉技術的進步滿足了弱勢族群的特殊醫療需求。遠端醫療和遠距監測工具為服務不足地區和農村地區的麻醉護理提供了支援。人工智慧（AI）在麻醉方案製定中的應用，有助於個別化劑量確定並建立預測患者預後的模型。 2024年5月，Panoramic Health在佛羅裡達州坦帕開設了一家先進的門診手術中心（ASC）。這家新中心旨在為各種醫療程序提供高品質、高效率的門診手術服務。該中心配備了最先進的技術，確保手術過程中更高的精準度、安全性和更好的患者療效。

吸入麻醉市場的發展趨勢：

麻醉劑和管理系統的不斷進步

製藥公司和醫療設備製造商正大力投資研發，以開發更有效、更安全的麻醉氣體和蒸氣。這些創新旨在透過降低副作用風險和改善整體麻醉體驗來改善患者預後。具有更優藥物動力學特性的新藥正在研發中，這些新藥能夠加快麻醉誘導和恢復，從而縮短患者在手術室的停留時間。Propofol（1-2.5 mg/kg，靜脈注射注射）是目前最常使用的全身麻醉誘導藥物。此外，包括精密蒸發器和監測技術在內的先進給藥系統的開發，確保了麻醉劑的精準給藥和劑量調整，最大限度地降低了過量或不足的風險。這些進步不僅有助於改善患者照護，也鼓勵醫療專業人員採用這些現代解決方案，從而推動吸入麻醉市場的成長。

手術數量和患者人數增加

人口成長通常伴隨著人口老化，這反過來又導致手術數量增加。老年人通常由於心臟病、關節重建和癌症治療等疾病而需要接受更多手術。在整形外科、心臟外科、腫瘤外科和一般外科等外科專科中，手術需要吸入麻醉。吸入麻醉因其起效迅速且能夠控制鎮靜深度，成為這些手術的首選。因此，吸入麻醉在維持患者無意識狀態和生命徵象穩定之間發揮平衡作用。此外，醫學知識和技術的進步正在擴大手術介入的範圍。根據美國國立衛生研究院 (NIH) 2022 年的報告，53% 的手術患者年齡在 65 歲或以上。微創手術、機器人輔助手術和其他創新技術的出現，使得手術介入更加安全快速。

門診手術中心擴建

門診手術中心 (ASC) 具有諸多優勢，包括成本效益高、患者住院時間短以及降低醫院感染風險。根據健康產業分銷商協會 (HIDA) 的數據顯示，截至 2023 年 6 月，門診手術中心患者人數超過 12 億，比疫情前水準增加了 13%。吸入麻醉起效迅速、恢復快，非常適合門診手術中心的需求。在門診手術中心接受各種手術的患者之所以選擇吸入麻醉，正是因為其恢復迅速。此外，吸入麻醉還能減少術後噁心嘔吐，使其在門診手術環境中極為實用。隨著門診手術服務需求的激增，吸入麻醉市場正經歷顯著成長，這也導致門診手術中心數量不斷增加。這種情況也促使製造商開發專為門診手術中心設計的便利攜帶式麻醉輸送設備。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球吸入麻醉市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • DESFLURANE
  • SEVOFLURANE
  • Isoflurane
  • 其他

第7章 市場區隔：依應用領域分類

  • 介紹
  • 維持

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC
    • Lunan Pharmaceutical Group Co. Ltd
    • Merck KGaA
    • Piramal Enterprises Ltd.
    • Troikaa Pharmaceuticals Ltd
Product Code: SR112026A3998

The global inhalation anesthesia market size reached USD 1.73 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.22 Billion by 2034, exhibiting a growth rate (CAGR) of 2.69% during 2026-2034. North America currently dominates the market, holding a market share of 52.8% in 2025. The growing number of people experiencing chronic medical conditions, along with collaborations among pharmaceutical firms, medical device companies, and healthcare institutions, is driving the market forward. Besides this, inhalation anesthesia market share is benefiting from the rising investments in advanced equipment by governments and private healthcare providers.

Increased government investments in healthcare facilities enhance access to surgical care and modern anesthetic technologies. Construction of new hospitals and surgical centers improves the availability of advanced inhalation anesthetic systems. Training programs for anesthesiologists in developing countries bolster the adoption of safe and effective anesthetics. Rising medical tourism in countries like India and Thailand increases the demand for inhalation anesthesia services. Advanced surgical procedures in emerging markets increases the use of modern anesthetic agents like sevoflurane and desflurane. Expanding health insurance coverage improves affordability and access to surgical treatments requiring inhalation anesthesia. Public-private partnerships (PPP) in healthcare projects promote the integration of advanced anesthetic technologies in underserved areas.

Innovative anesthesia machines allow precise monitoring and controlled delivery of inhalation anesthetics during surgical procedures. Improved pharmacokinetics of agents like sevoflurane enable rapid induction and faster post-operative recovery times. Integrated software systems in anesthesia machines enhance workflow efficiency and reduce risks of human error. Non-invasive monitoring technologies ensure real-time feedback on patient vitals, optimizing anesthesia administration and patient safety. Portable and compact anesthesia devices are increasingly utilized in outpatient settings and ambulatory surgical centers. Development of environmentally friendly anesthetic agents reduces the environmental impact of traditional inhalation anesthetics. Advancements in pediatric and geriatric anesthesia techniques cater to specialized healthcare needs in vulnerable populations. Telemedicine and remote monitoring tools support anesthetic care in underserved and rural areas. Artificial intelligence (AI) integration in anesthesia planning aids in personalized dosing and predictive patient outcome models. In May 2024, Panoramic Health launched a state-of-the-art ambulatory surgery center (ASC) in Tampa, Florida. The new center aims to provide high-quality, efficient outpatient surgical services for various medical procedures. Equipped with the latest technologies, the facility ensures precision, safety, and improved patient outcomes during surgeries.

INHALATION ANESTHESIA MARKET TRENDS:

Continual advancements in anesthetic agents and delivery systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development (R&D) to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. The most often used medication to induce general anesthesia is propofol (1 to 2.5 mg/kg IV). Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus impelling the inhalation anesthesia market growth.

Rising surgical procedures and patient volume

Population growth is normally associated with aging, which calls for increased numbers of surgical operations. The elderly generally require more operations because of conditions like heart diseases, replacements of joints, and treatments of cancer. Surgeon specialties including orthopedic, cardiology, oncology, and general surgery, require inhalation anesthesia for surgeries. Inhalation anesthesia becomes a preferred choice for these interventions because it produces immediate and controllable depth of sedation. It therefore constitutes a balance between the unconsciousness of the patient and stability of vitals. Additionally, the growth of medical knowledge and technology has stretched the scope of possible surgical interventions. As per the National Institute of Health in 2022, 53% of surgical patients were aged 65 years or older. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques are emerging that allow for safer and quicker interventions.

Expansion of ambulatory surgical centers

Ambulatory surgical centers (ASCs) provide many benefits, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. ACS patient volumes exceeded 1.2 billion in June 2023, a 13% increase from pre-pandemic levels, based on data from the Health Industry Distributors Association. Inhalation anesthesia fits well with the needs of ASCs because of its rapid onset and quick recovery profile. Patients who present themselves for various procedures at ASCs opt for inhalation anesthesia because it offers quick recovery. Additionally, post-operative nausea and vomiting that occur after being under anesthesia are less in inhalation type, making it precious in an ambulatory setting. The market of inhalation anesthesia is experiencing substantial growth as more and more ASCs are required to meet the surging requirement of outpatient surgical services. It also encourages producers to create user-friendly and mobile anesthesia delivery devices designed for use in ASC settings.

INHALATION ANESTHESIA INDUSTRY SEGMENTATION:

Analysis by Product:

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Others

Sevoflurane is the leading market with 56.0% market share in 2025. Based on the study, sevoflurane is gaining traction, and this is significantly attributed to the favorable pharmacokinetic profile. This agent allows for rapid induction so that anesthesiologists can guide the patient quickly and smoothly into and out of anesthesia. This, in turn, not only makes the process in the medical facilities more efficient but also ensures that patients face minimal delay in the onset and offset of surgical procedures. In addition, the low blood-gas solubility of sevoflurane enables equilibration between the lungs and the bloodstream very quickly, meaning quicker adjustments in the depth of anesthesia, consequently leading to quicker recoveries. This makes sevoflurane less likely to cause organ toxicity or compromise of vital functions and provides some level of reassurance to medical practitioners and patients alike. The safety profile has thus been crucial in making sevoflurane a staple of inhalation anesthesia practice, especially in pediatric and geriatric populations, where safety is of paramount importance.

Analysis by Application:

  • Induction
  • Maintenance

Maintenance dominates the market with 55.7% of market share in 2025. According to the report, maintenance ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Analysis by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Hospitals hold the largest market share with 67.8% of market share in 2025. Hospitals are a comprehensive healthcare provider that offer the full spectrum of medical services including routine surgeries, emergency interventions, and specialized procedures in various specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a significant demand for anesthesia services. Inhalation anesthesia, which is capable of rapid induction and adjustable levels of sedation, fits seamlessly into the changing hospital operating rooms' environment. They are also equipped with advanced operating theaters, high technology monitoring systems, and experienced teams of anesthetists for handling a variety of cases. Such a well-established infrastructure allows the hospitals to effectively handle all the complexities arising with different kinds of surgeries that demand inhalation anesthesia. Besides, the fact that there exist separate units like pediatric and cardiac surgery departments within hospitals reflects the applicability of inhalation anesthesia to varied patient groups and different kinds of surgical interventions.

Regional Analysis

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 52.8%. North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. For example, in April 2024, Commons Clinic invested $9.75 million in launching an advanced spine surgery center in the United States. The center will feature a next-generation ambulatory surgical platform designed to enhance surgical efficiency. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the US Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

KEY REGIONAL TAKEAWAYS:

UNITED STATES INHALATION ANESTHESIA MARKET ANALYSIS

The United States hold 84.80% of the market share in North America. The main factors driving the inhalation anesthesia market demand in the United States are the increasing count of surgical procedures, the aging population, and improvements in healthcare infrastructure. According to paper published in ResearchGate, nearly 310 million major surgeries are conducted every year, with a big share going to the United States due to its developed healthcare system and high demand for surgery. According to the American Heart Association, over 121 million people suffering from chronic conditions that include cardiovascular disorders, which increases the demand for inhaled anesthesia systems, which can ensure safety, efficacy, of such anesthetic anesthesia delivery. The increasing demand for minimal invasive surgical practices, which boast shorter recovery time and fewer postoperative complications, further fuels this demand for inhalation anesthesia. Significant US manufacturers and increased interest in the need for balanced anesthesia also help propel the growth within the market.

EUROPE INHALATION ANESTHESIA MARKET ANALYSIS

The market in Europe is driven by a robust healthcare system and the demographic of an ageing population. Europe has an aging population with 20% being 65 years or older as revealed by Eurostat. Long-term illnesses, such as cancer and neurological diseases require surgery hence, there is a considerable growth in demand for this medical procedure. More than 3.9 million cancer cases are reported in Europe, as per an industry report. Thus, it is important to have efficient solutions for anesthesia during surgeries. In addition, the European Union's emphasis on raising the healthcare standards and promoting minimally invasive surgical methods aids in market expansion. The government initiatives to enhance surgical treatment accessibility also increases the demand for inhalation anesthetics, such as desflurane and isoflurane. The extensive surgery volume and state-of-the-art medical facilities in countries like Germany, France, and the UK make them major contributors.

ASIA PACIFIC INHALATION ANESTHESIA MARKET ANALYSIS

Increasing populations, demand for surgeries, and healthcare infrastructural development drive the market for inhalation anesthesia in the Asia-Pacific. According to reports growing population with surgery demands in a country like China and India, comprising more than 36% of world population. Along with this, growing chronic diseases burden, especially the among diabetic population and the risk of cardiovascular problems, are leading to more surgeries in the region. For instance, according to an industry report, China documented more than 4.8 million new cancer cases in 2022 alone, which is the driving factor to promote the demand for effective anesthesia. The market is therefore expanding due to the increasing medical tourism sites in countries like Malaysia, Singapore, and Thailand. Moreover, the increasing adoption of advanced anesthesia delivery systems and government initiatives to expand access to quality healthcare ensure the high adoption of inhalation anesthetics, such as halothane and sevoflurane.

LATIN AMERICA INHALATION ANESTHESIA MARKET ANALYSIS

Increasing surgical procedures and improvement in healthcare facilities are driving the market in Latin America. Based on the 2019 estimates from the Global Procedure Volume Tracker of LSI, the three procedure types with the greatest volume in Brazil, includes obstetrical and gynecological procedures (4.4 million); general surgical procedures (3.2 million); and aesthetic, dermatological and plastic surgery related procedures (1.7 million). Increasing trends of lifestyle-associated disorders, obesity, and other cardiovascular diseases accelerate the adoption rate of inhalation anesthetics due to heightened surgical needs. In countries like Costa Rica and Colombia, affordable surgical procedures attract the inflow of patients from overseas. Medical tourism is also picking up in these regions. Additional incentives are emerging due to this region's heightened emphasis on improving safety when utilizing anesthesia and incorporating advanced technologies for its administration. Additionally, collaborations between global medical technology firms and local healthcare providers facilitate access to high-quality anesthesia products.

MIDDLE EAST AND AFRICA INHALATION ANESTHESIA MARKET ANALYSIS

Growing investments in healthcare infrastructure and increased focus on surgical treatment are fueling the market growth in the Middle East and Africa. The Gulf Cooperation Council (GCC) countries including the United Arab Emirates and Saudi Arabia, lead the region in modern surgical capabilities with more than 1.8 million surgeries in 2022, as per reports. The region is experiencing more cases of chronic diseases like diabetes and cancer, which requires surgical interventions. The modernization of healthcare systems is being made by governments by investing in cutting-edge anesthesia equipment. Increased access to surgical treatment is through international collaborations and assistance initiatives in Africa, hence rising the demand for inhalation anesthetics, such as halothane and isoflurane.

COMPETITIVE LANDSCAPE:

Pharmaceutical and medical device companies are heavily investing in research and development (R&D) to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moreover, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbvie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Ltd.
  • Troikaa Pharmaceuticals Ltd.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the inhalation anesthesia market?

2. What is the future outlook of inhalation anesthesia market?

3. What are the key factors driving the inhalation anesthesia market?

4. Which region accounts for the largest inhalation anesthesia market share?

5. Which are the leading companies in the global inhalation anesthesia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Desflurane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sevoflurane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Isoflurane
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Induction
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Maintenance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbvie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Halocarbon Products Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Hikma Pharmaceuticals PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lunan Pharmaceutical Group Co. Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Merck KGaA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Piramal Enterprises Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Troikaa Pharmaceuticals Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
  • Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2025
  • Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
  • Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
  • Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
  • Table 7: Global: Inhalation Anesthesia Market: Key Players